CN104147536A - 一种治疗痔疮的药物组合物及其制备方法 - Google Patents
一种治疗痔疮的药物组合物及其制备方法 Download PDFInfo
- Publication number
- CN104147536A CN104147536A CN201410429302.0A CN201410429302A CN104147536A CN 104147536 A CN104147536 A CN 104147536A CN 201410429302 A CN201410429302 A CN 201410429302A CN 104147536 A CN104147536 A CN 104147536A
- Authority
- CN
- China
- Prior art keywords
- parts
- hemorrhoid
- blood
- preparation
- medicine composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 208000014617 hemorrhoid Diseases 0.000 title claims abstract description 49
- 238000002360 preparation method Methods 0.000 title claims abstract description 28
- 239000000203 mixture Substances 0.000 title claims abstract description 16
- 239000003814 drug Substances 0.000 title abstract description 50
- 229940079593 drug Drugs 0.000 title abstract description 12
- 241000255791 Bombyx Species 0.000 claims abstract description 21
- 235000009411 Rheum rhabarbarum Nutrition 0.000 claims abstract description 9
- 239000004615 ingredient Substances 0.000 claims abstract description 7
- 241000931705 Cicada Species 0.000 claims abstract description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 44
- 239000000843 powder Substances 0.000 claims description 30
- 239000000284 extract Substances 0.000 claims description 24
- 239000008187 granular material Substances 0.000 claims description 24
- 229920000858 Cyclodextrin Polymers 0.000 claims description 22
- 239000001116 FEMA 4028 Substances 0.000 claims description 22
- 241000628997 Flos Species 0.000 claims description 22
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 claims description 22
- 235000011175 beta-cyclodextrine Nutrition 0.000 claims description 22
- 229960004853 betadex Drugs 0.000 claims description 22
- 150000001875 compounds Chemical class 0.000 claims description 22
- 239000000341 volatile oil Substances 0.000 claims description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 18
- 239000000463 material Substances 0.000 claims description 17
- 239000011248 coating agent Substances 0.000 claims description 14
- 238000000576 coating method Methods 0.000 claims description 14
- 238000001035 drying Methods 0.000 claims description 13
- 239000008194 pharmaceutical composition Substances 0.000 claims description 12
- 239000002775 capsule Substances 0.000 claims description 11
- 239000002245 particle Substances 0.000 claims description 11
- 241000219061 Rheum Species 0.000 claims description 8
- 230000006837 decompression Effects 0.000 claims description 8
- 238000007908 dry granulation Methods 0.000 claims description 8
- 239000002702 enteric coating Substances 0.000 claims description 8
- 238000009505 enteric coating Methods 0.000 claims description 8
- 238000002481 ethanol extraction Methods 0.000 claims description 8
- 239000007788 liquid Substances 0.000 claims description 8
- 238000004064 recycling Methods 0.000 claims description 8
- 238000010992 reflux Methods 0.000 claims description 8
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 7
- 239000012530 fluid Substances 0.000 claims description 7
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 7
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 7
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 7
- 239000000945 filler Substances 0.000 claims description 6
- 239000002671 adjuvant Substances 0.000 claims description 5
- 238000007670 refining Methods 0.000 claims description 5
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 4
- 229930195725 Mannitol Natural products 0.000 claims description 4
- 239000003463 adsorbent Substances 0.000 claims description 4
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 claims description 4
- 239000012141 concentrate Substances 0.000 claims description 4
- 238000005202 decontamination Methods 0.000 claims description 4
- 230000003588 decontaminative effect Effects 0.000 claims description 4
- 239000003480 eluent Substances 0.000 claims description 4
- 238000010828 elution Methods 0.000 claims description 4
- 239000000594 mannitol Substances 0.000 claims description 4
- 235000010355 mannitol Nutrition 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- 238000012856 packing Methods 0.000 claims description 4
- 230000002829 reductive effect Effects 0.000 claims description 4
- 239000011347 resin Substances 0.000 claims description 4
- 229920005989 resin Polymers 0.000 claims description 4
- 239000011265 semifinished product Substances 0.000 claims description 4
- 238000005406 washing Methods 0.000 claims description 4
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 3
- 239000002552 dosage form Substances 0.000 claims description 3
- 239000008101 lactose Substances 0.000 claims description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 2
- 229920002472 Starch Polymers 0.000 claims description 2
- 239000000741 silica gel Substances 0.000 claims description 2
- 229910002027 silica gel Inorganic materials 0.000 claims description 2
- 239000008107 starch Substances 0.000 claims description 2
- 235000019698 starch Nutrition 0.000 claims description 2
- 239000000725 suspension Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 15
- 210000002784 stomach Anatomy 0.000 abstract description 15
- 241000168720 Panax japonicus Species 0.000 abstract description 3
- 239000002253 acid Substances 0.000 abstract description 3
- 241000037488 Coccoloba pubescens Species 0.000 abstract 1
- 235000014375 Curcuma Nutrition 0.000 abstract 1
- 244000164480 Curcuma aromatica Species 0.000 abstract 1
- 235000005769 Japanese ginseng Nutrition 0.000 abstract 1
- 235000003174 Panax japonicus Nutrition 0.000 abstract 1
- 240000002924 Platycladus orientalis Species 0.000 abstract 1
- 244000299790 Rheum rhabarbarum Species 0.000 abstract 1
- 241000501113 Sargentodoxa cuneata Species 0.000 abstract 1
- 241000219784 Sophora Species 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 abstract 1
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 description 67
- 239000008280 blood Substances 0.000 description 67
- 210000000436 anus Anatomy 0.000 description 19
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 17
- 208000002193 Pain Diseases 0.000 description 15
- 208000001848 dysentery Diseases 0.000 description 15
- 201000010099 disease Diseases 0.000 description 14
- 210000004072 lung Anatomy 0.000 description 14
- 206010040943 Skin Ulcer Diseases 0.000 description 13
- 231100000019 skin ulcer Toxicity 0.000 description 13
- 239000007789 gas Substances 0.000 description 11
- 230000023597 hemostasis Effects 0.000 description 11
- 210000004185 liver Anatomy 0.000 description 11
- 230000008961 swelling Effects 0.000 description 11
- 206010010904 Convulsion Diseases 0.000 description 10
- 206010027514 Metrorrhagia Diseases 0.000 description 10
- 230000000968 intestinal effect Effects 0.000 description 10
- 208000006820 Arthralgia Diseases 0.000 description 9
- 230000036461 convulsion Effects 0.000 description 9
- 230000006870 function Effects 0.000 description 9
- 239000002398 materia medica Substances 0.000 description 9
- 238000002560 therapeutic procedure Methods 0.000 description 9
- 230000008034 disappearance Effects 0.000 description 8
- 208000001780 epistaxis Diseases 0.000 description 8
- 208000035861 hematochezia Diseases 0.000 description 8
- 230000001717 pathogenic effect Effects 0.000 description 8
- 208000003251 Pruritus Diseases 0.000 description 7
- 238000001816 cooling Methods 0.000 description 7
- 210000002429 large intestine Anatomy 0.000 description 7
- 201000007227 lymph node tuberculosis Diseases 0.000 description 7
- 206010037844 rash Diseases 0.000 description 7
- 208000010201 Exanthema Diseases 0.000 description 6
- 206010062717 Increased upper airway secretion Diseases 0.000 description 6
- 210000001015 abdomen Anatomy 0.000 description 6
- 230000017531 blood circulation Effects 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 6
- 201000005884 exanthem Diseases 0.000 description 6
- 239000003172 expectorant agent Substances 0.000 description 6
- 230000003419 expectorant effect Effects 0.000 description 6
- 241000411851 herbal medicine Species 0.000 description 6
- 210000000936 intestine Anatomy 0.000 description 6
- 208000026435 phlegm Diseases 0.000 description 6
- 231100000614 poison Toxicity 0.000 description 6
- 210000000952 spleen Anatomy 0.000 description 6
- 206010007247 Carbuncle Diseases 0.000 description 5
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 5
- 208000032843 Hemorrhage Diseases 0.000 description 5
- 230000002411 adverse Effects 0.000 description 5
- 230000013872 defecation Effects 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 244000052769 pathogen Species 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 231100000331 toxic Toxicity 0.000 description 5
- 230000002588 toxic effect Effects 0.000 description 5
- 206010017553 Furuncle Diseases 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 239000000084 colloidal system Substances 0.000 description 4
- 201000006549 dyspepsia Diseases 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 238000000227 grinding Methods 0.000 description 4
- 210000004877 mucosa Anatomy 0.000 description 4
- 210000003097 mucus Anatomy 0.000 description 4
- 239000002574 poison Substances 0.000 description 4
- 238000010926 purge Methods 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 210000001835 viscera Anatomy 0.000 description 4
- 206010000087 Abdominal pain upper Diseases 0.000 description 3
- 206010063409 Acarodermatitis Diseases 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 3
- 201000000297 Erysipelas Diseases 0.000 description 3
- 208000034507 Haematemesis Diseases 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 3
- 206010068319 Oropharyngeal pain Diseases 0.000 description 3
- 201000007100 Pharyngitis Diseases 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 208000025747 Rheumatic disease Diseases 0.000 description 3
- 241000447727 Scabies Species 0.000 description 3
- 208000025865 Ulcer Diseases 0.000 description 3
- 206010052428 Wound Diseases 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 230000000202 analgesic effect Effects 0.000 description 3
- 230000001174 ascending effect Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 238000005520 cutting process Methods 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 206010015037 epilepsy Diseases 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 201000007772 internal hemorrhoid Diseases 0.000 description 3
- 230000007803 itching Effects 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 229940126701 oral medication Drugs 0.000 description 3
- 230000008506 pathogenesis Effects 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 230000000552 rheumatic effect Effects 0.000 description 3
- 208000005687 scabies Diseases 0.000 description 3
- 238000004611 spectroscopical analysis Methods 0.000 description 3
- 230000004936 stimulating effect Effects 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- 201000008827 tuberculosis Diseases 0.000 description 3
- 231100000397 ulcer Toxicity 0.000 description 3
- 210000001113 umbilicus Anatomy 0.000 description 3
- 206010002953 Aphonia Diseases 0.000 description 2
- 206010003011 Appendicitis Diseases 0.000 description 2
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 2
- 206010012218 Delirium Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 208000015817 Infant Nutrition disease Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- AXVZFRBSCNEKPQ-UHFFFAOYSA-N N-methyltyramine Chemical compound CNCCC1=CC=C(O)C=C1 AXVZFRBSCNEKPQ-UHFFFAOYSA-N 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 206010040844 Skin exfoliation Diseases 0.000 description 2
- 206010043376 Tetanus Diseases 0.000 description 2
- 208000024780 Urticaria Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 206010000269 abscess Diseases 0.000 description 2
- 210000002255 anal canal Anatomy 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000000840 anti-viral effect Effects 0.000 description 2
- 201000007201 aphasia Diseases 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 235000019658 bitter taste Nutrition 0.000 description 2
- 208000034158 bleeding Diseases 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 239000000812 cholinergic antagonist Substances 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 230000003628 erosive effect Effects 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 210000003608 fece Anatomy 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 208000021760 high fever Diseases 0.000 description 2
- 239000006194 liquid suspension Substances 0.000 description 2
- 230000002175 menstrual effect Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 231100000862 numbness Toxicity 0.000 description 2
- 201000005111 ocular hyperemia Diseases 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000001047 pyretic effect Effects 0.000 description 2
- 238000012827 research and development Methods 0.000 description 2
- 201000003068 rheumatic fever Diseases 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- 230000035943 smell Effects 0.000 description 2
- 230000002048 spasmolytic effect Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 210000004243 sweat Anatomy 0.000 description 2
- 208000004371 toothache Diseases 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010000084 Abdominal pain lower Diseases 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical group CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 206010061623 Adverse drug reaction Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 208000019751 Anorectal disease Diseases 0.000 description 1
- 241000208340 Araliaceae Species 0.000 description 1
- 208000019838 Blood disease Diseases 0.000 description 1
- 206010006895 Cachexia Diseases 0.000 description 1
- 241000345998 Calamus manan Species 0.000 description 1
- 206010007191 Capillary fragility Diseases 0.000 description 1
- 240000004528 Catalpa ovata Species 0.000 description 1
- 235000010005 Catalpa ovata Nutrition 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- 206010010144 Completed suicide Diseases 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010011469 Crying Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 208000019505 Deglutition disease Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- 206010051244 Dyschezia Diseases 0.000 description 1
- 206010013911 Dysgeusia Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 206010013952 Dysphonia Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 241000498255 Enterobius vermicularis Species 0.000 description 1
- 206010015958 Eye pain Diseases 0.000 description 1
- 206010016807 Fluid retention Diseases 0.000 description 1
- 206010060710 Galactostasis Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 206010054787 Haemorrhoidal haemorrhage Diseases 0.000 description 1
- 208000010473 Hoarseness Diseases 0.000 description 1
- 241001083838 Lardizabalaceae Species 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 208000005647 Mumps Diseases 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 235000004449 Panax japonicus var bipinnatifidus Nutrition 0.000 description 1
- 241000180649 Panax notoginseng Species 0.000 description 1
- 235000003143 Panax notoginseng Nutrition 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 241000112598 Pseudoblennius percoides Species 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000004680 Rectal Fistula Diseases 0.000 description 1
- 208000015815 Rectal disease Diseases 0.000 description 1
- 206010057071 Rectal tenesmus Diseases 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 241000797989 Rheum forrestii Species 0.000 description 1
- 244000046101 Sophora japonica Species 0.000 description 1
- 235000010586 Sophora japonica Nutrition 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 206010044684 Trismus Diseases 0.000 description 1
- 206010046814 Uterine prolapse Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 206010002156 anal fistula Diseases 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 230000000507 anthelmentic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001355 anti-mycobacterial effect Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 208000034526 bruise Diseases 0.000 description 1
- 230000009172 bursting Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 230000001055 chewing effect Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 239000003405 delayed action preparation Substances 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 208000026500 emaciation Diseases 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 206010014881 enterobiasis Diseases 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 208000024756 faint Diseases 0.000 description 1
- 239000003664 filaricide agent Substances 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000010135 fructus aurantii immaturus Substances 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000030136 gastric emptying Effects 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 208000010805 mumps infectious disease Diseases 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 230000000324 neuroprotective effect Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000001175 peptic effect Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical compound OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 1
- 208000015768 polyposis Diseases 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 239000002510 pyrogen Substances 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 235000012950 rattan cane Nutrition 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 208000012271 tenesmus Diseases 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 210000003905 vulva Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及一种治疗痔疮的药物组合物及其制备方法,其特征在于由以下重量份的药物组成:炒槐米10~35份、侧柏叶10~40份、枳壳5~20份、荆芥5~20份、僵蚕5~25份、蝉蜕5~20份、姜黄10~30份、大黄5~20份、珠儿参5-20份、大血藤15-40份。本发明药物经过多年研究,临床治疗效果明显,治愈率为46%以上,总有效率为96%以上,具有疗效好、治愈率高、无副作用等特点。本发明的肠溶制剂,可克服胃强酸、光、热等内外环境对有效成分的破坏,增加药物的稳定性,确保活性成分在肠道力完全释放,充分发挥药物的疗效。
Description
技术领域
本发明涉及一种药物组合物,特别是涉及一种治疗痔疮的药物组合物及其制备方法。
背景技术
痔疮是一种位于肛门部位的常见疾病,约占肛肠疾患中的87.25%。任何年龄都可发病,但随着年龄增长,发病率逐渐增高。素有“十男九痔”、“十女十痔”的说法,通常反复发作,不易治愈。痔疮的诱发因素很多,其中便秘、长期饮酒、进食大量刺激性食物和久坐久立是主要诱因。西医关于痔疮的病因主要有两种学说,一是静脉曲张学说,认为痔是直肠下段黏膜下和肛管皮肤下的静脉丛淤血、扩张和屈曲所形成的静脉团。目前广为接受的理论是Thomson的肛垫下移学说,认为痔原本是肛管部位正常的解剖结构,即血管垫,是齿状线及以上1.5cm的环状海绵样组织带。只有肛垫组织发生异常并合并有症状时,才能称为痔,才需要治疗,治疗目的是解除症状,而非消除痔体。目前西医对痔疮采取内服药、外用药及手术治疗等方法。
目前西医对痔疮采取内服药、外用药及手术治疗等方法。手术治疗病人痛苦,而且易复发;目前治疗痔疮的药物,大多为各种痔疮膏、栓剂等涂抹在患处,但外用药虽然起效快,但载药量小、依从性差,疗效不稳定,病情易反复;而口服药物经肠胃吸收,药效抵达患病部位需较长时间,但有效成分需先经过胃消化才能到达肠道进行吸收,发挥疗效。由于种种原因,其治疗效果不理想,满足不了人们对治疗痔疮药物上的需求。因此研制新的治疗痔疮的药物为人们所关心。肠溶颗粒为肠道定向释药的控释制剂,由于其受胃排空因素影响小,且有崩解时限波动小,吸收稳定等特点,近年来为国内外竞相研究与开发的药物新剂型。中药制剂由于受传统制药工艺、药用辅料等因素的制约,其剂型的研究受到一定程度的限度。本项目的开发必将推动中药制剂的研究和开发。
发明内容
本发明提供了一种效果明显、有效率、治愈率高,治疗痔疮的药物组合物及其制备方法。
本发明是通过以下技术方案实现的:
一种治疗痔疮的药物组合物,其特征在于由以下重量份的药物组成:炒槐米10~35份、侧柏叶10~40份、枳壳5~20份、荆芥5~20份、僵蚕5~25份、蝉蜕5~20份、姜黄10~30份、大黄5~20份、珠儿参5-20份、大血藤15-40份。
优选的,所述的一种治疗痔疮的药物组合物,其特征在于由以下重量份的药物组成:炒槐米20~25份、侧柏叶20~25份、枳壳10~15份、荆芥10~15份、僵蚕10~20份、蝉蜕10~15份、姜黄15~20份、大黄10~15份、珠儿参10-15份、大血藤25-30份。
优选的,所述药物组合物的剂型为颗粒剂、肠溶片或肠溶胶囊。
优选的,所述的治疗痔疮的颗粒剂的制备方法,其特征在于包括以下步骤:取炒槐米、侧柏叶、珠儿参、大血藤和姜黄,加8-12倍量50-70%的乙醇提取2次,每次0.5-1.0小时,合并醇提取液减压回收乙醇;荆芥加水12-15倍量,浸泡3小时后,回流提取8小时提取挥发油,挥发油采用β-环糊精包合制得β-环糊精包合粉;上述两药渣与其余枳壳、僵蚕、蝉蜕和大黄药材混合,加8-10倍量水提取2次,每次1.0-1.5小时;合并上述提取液浓缩至相对密度1.25(60 ℃),减压干燥,粉碎,得干粉;干粉加入适量辅料和β-环糊精包合粉充分混匀,干式制粒,整粒,包装,即得颗粒剂。更进一步优选的,所述辅料为重量比为1:3的微晶纤维素和甘露醇,所述辅料的重量为干粉重量的20-50%。
优选的,权利要求3所述的治疗痔疮的肠溶胶囊的制备方法,其特征在于包括以下步骤:取炒槐米、侧柏叶、珠儿参、大血藤和姜黄,加8-12倍量50-70%的乙醇提取2次,每次0.5-1.0小时,合并醇提取液减压回收乙醇;荆芥加水12-15倍量,浸泡3小时后,回流提取8小时提取挥发油,挥发油采用β-环糊精包合制得β-环糊精粉;上述两药渣与其余枳壳、僵蚕、蝉蜕和大黄药材混合,加8-10倍量水提取2次,每次1.0-1.5小时;合并上述提取液浓缩至相对密度1.02-1.06,上大孔吸附树脂进行吸附,水洗去杂质,50-70%的乙醇洗脱,收集洗脱液,浓缩干燥,粉碎,制得精制干粉;加入适量填充剂,混合、干法制粒、整粒得半成品颗粒,取肠溶衣材料混悬液用流化床对中间体颗粒进行包衣,包衣增重10%-30%,包衣结束后,40℃流化干燥30min,即得肠溶颗粒,装胶囊,即得肠溶胶囊。更进一步优选的,所述填充剂为乳糖、微晶纤维素、微粉硅胶、硫酸钙、淀粉中的一种或几种,所述填充剂的重量为精制干粉重量的20-30%。更进一步优选的,所述肠溶衣材料为尤特奇L100或尤特奇S100或尤特奇L30D-55;包衣增重优选增重为20%。
本发明的方药组方分析:
槐米:为豆科植物槐SophorajaponicaL.的花蕾。炒槐米为槐米用文火微炒而入药者,可减缓苦寒之性。性微寒,味苦。归大肠经。功能主治:凉血止血,清肝泻火。用于便血、痔血、血痢、崩漏、吐血、衄血、肝热目赤、头痛眩晕。《日华子本草》:治五痔,心痛,眼赤,杀腹藏虫及热,治皮肤风,并肠风泻血,赤白痢。《医学启源》:纲目:炒香频嚼,治失音及喉痹。又疗吐血,衄,崩中漏下。凉大肠热。《本草求原》:为凉血要药。现代研究表明槐米有抗炎、抗病毒、增强毛细血管抵抗力,减少毛细血管脆性等作用。
侧柏叶:性微寒,味苦涩。归肺、肝、大肠经。涩能收敛,苦寒则清热凉血,故为收敛、凉血之要药。功能主治:凉血,止血,祛风湿,散肿毒。治吐血、衄血、尿血、血痢、肠风、崩漏,风湿痹痛。《别录》:"主吐血、衄血、痢血、崩中赤白。轻身益气,令人耐寒暑,去湿痹,生肌。《本草正》:善清血凉血,去湿热湿痹,骨节疼痛。捣烂可敷火丹,散痄腮肿痛热毒。《百一选方》:治痔、肠风、脏毒、下血不止。《普济方》:治肠风、脏毒,酒痢,下血不止。《医林纂要》:泄肺逆,泻心火,平肝热,清血分之热。《岭南采药录》:凉血行气,祛风,利小便,散瘀。《本草衍义补遗》:柏叶,补阴之要药,其性多燥,久得之,大益脾土,以滋其肺。《本草汇言》:侧柏叶,止流血,去风湿之药也。现代研究表明侧柏叶具凉血止血、抗菌、抗病毒及神经保护、抗红细胞氧化等作用。
枳壳:性味苦、酸、性微寒。归肺、脾、肝、胃、大肠经。功能主治:具有理气宽中,行滞消胀等功效,主治胸膈痞满,胁肋胀痛,积食不化,脘腹胀满,下痢后重,脱肛,子宫脱垂。《本草纲目》:其功皆能利气,气下则痰喘止,气行则痞胀消,气通则痛刺止,气利则后重除,故以枳实利胸膈,枳壳利肠胃。《博济方》:治远年近日肠风下血不止。《经验方》:治产后生肠不收。《日华子本草》:健脾开胃,调五脏,下气,止呕逆,消痰。治反胃,霍乱泻痢,消食,破症结痃癖,五膈气,除风明目及肺气水肿,利大小肠,皮肤痒。痔肿可炙熨。现代研究表明:枳壳中所含的N-甲基酪胺增加冠脉流量和肾血流血,降低心肌氧耗量和明显的利尿作用。
荆芥:味辛、微苦、性微温。入肺、肝经。功能主治:具有解表散风,透疹,消疮、止血之功,治感冒发热,头痛,咽喉肿痛,中风口噤,吐血,衄血,便血;崩漏,产后血晕;痈肿,疮疥,瘰疬。《本经》:主寒热,鼠瘘,瘰疬生疮,破结聚气,下瘀血,除湿痹。《本草图经》:治头风,虚劳,疮疥,妇人血风。《本草纲目》:散风热,清头目,利咽喉,消疮肿。治项强,目中黑花,及生疮,阴颓,吐血,衄血,下血,血痢,崩中,痔漏。现代研究表明荆芥具抗结核杆菌之作用。
僵蚕:味辛咸,性平。入肝、肺,胃经。功能主治:祛风解痉,化痰散结。治中风失音,惊痫,头风,喉风。喉痹,瘰疬结核。风疮瘾疹,丹毒,乳腺炎。《本经》:主小儿惊痫夜啼,去三虫,灭黑黚,男子阴疡病。《日华子本草》:治中风失音,并一切风疾,小儿客忤,男子阴痒痛,女子带下。《医学启源》:去皮肤间诸风。《纲目》:散风痰结核,瘰疬,头风,风虫齿痛,皮肤风疮,丹毒作痒,痰疟癥结,妇人乳汁不通,崩中下血,小儿疳蚀鳞体,一切金疮,疔肿风痔。《玉楸药解》:活络通经,驱风开痹。治头痛胸痹,口噤牙疼,瘾疹风瘙;烧研酒服,能溃痈破顶,又治血淋崩中。
蝉蜕:味甘,性寒。归肺、肝经。功能主治:散风除热,利咽,透疹,退翳,解痉。用于风热感冒,咽痛,音哑,麻疹不透,风疹瘙痒,目赤翳障,惊风抽搐,破伤风。《别录》:主小儿痫;灰服之主久痢。《药性论》:治小儿浑身壮热惊痫,兼能止渴。《纲目》:治头风眩运,皮肤风热,痘疹作痒,破伤风及疗肿毒疮,大人失音,小儿噤风天吊,惊哭夜啼,阴肿。
大黄:味苦,性寒。入胃、大肠、肝经。功能主治:泻热毒,破积滞,行瘀血。治实热便秘,谵语发托,食积痞满,痢疾初起,里急后重,瘀停经闭,症瘕积聚,时行热疫,暴眼赤痛,吐血,衄血,阳黄,水肿,淋浊,溲亦,痈疡肿毒,疔疮,汤火伤。《本经》:下瘀血,血闭,寒热,破症瘕积聚,留饮宿食,荡涤肠胃,推陈致新,通利水谷,调中化食,安和五脏。《别录》:平胃,下气,除痰实,肠间结热,心腹胀满,女子寒血闭胀,小腹痛,诸老血留结。《药性论》:主寒热,消食,炼五脏,通女子经候,利水肿,破痰实,冷热积聚,宿食,利大小肠,贴热毒肿,主小儿寒热时疾,烦热,蚀脓,破留血。《日华子本草》:"通宣一切气,调血脉,利关节,泄塑滞、水气,四肢冷热不调,温瘴热痰,利大小便,并敷-切疮疖痈毒。《纲目》:主治下痢亦白,里急腹痛,小便淋沥,实热燥结,潮热谵语,黄疸,诸火疮。
珠儿参:【别名】珠参(《纲目拾遗》),珠子参、疙瘩七(《中药形性经验鉴别法》),雪三七(《中药材品种论述》),钮子七、扣子七(《民间常用草药汇编》)。【来源】为五加科植物大叶三七 Panax japonicas C. A. Mey. var. major(Burkill)C. Y. Wu et K. M. Feng的呈串珠状的根茎。味苦甘,性寒。【功能主治】养阴,清肺,散瘀,止血,定痛。治热病烦渴,阴虚咳嗽,痨伤吐血,鼻衄,咽痛,风湿性关节炎,小儿惊风,跌打损伤。《本草从新》:补肺,降火。肺热者宜之。《救生苦海》:血症用之,可代三七。《药性考》:能托里,外症堪用。《四川中药志》:散瘀,止血,定痛。治跌扑损伤,痨伤吐血,崩中下血。《陕西中草药》:镇惊熄风,除风湿,理气健胃,止痛。治小儿惊风,风湿性关节炎,胃痛,肿毒恶疮。《本草从新》:珠儿参,味厚体重,其性大约与西洋人参相同,不过清热之功;热去则火不刑金而肺脏受益,非真能补也。出闽中,须多去皮,再用滚水泡,以其苦劣之味在外皮,近中心则苦味减而稍甘。
大血藤:为木通科植物大血藤Sargentodoza cuneata (Oliv.)Rehd.et Wils.酌干燥藤茎。味苦,性平。归大肠、肝经。功能与主治:清热解毒,活血,祛风止痛。用于肠痈腹痛,热毒疮疡,经闭,痛经,跌扑肿痛,风湿痹痛。《本草图经》:攻血,治血块。《中药志》:祛风通经络,利尿杀虫。治肠痈,风湿痹痛,麻风,淋病:蛔虫腹痛。《湖南药物志》:通经补血,强筋壮骨,驱虫。治跌打损伤,风湿疼痛,血晕,血淋,筋骨疼痛,疮疖,血丝虫病。《陕西中草药》:抗菌消炎,消肿散结,理气活血,祛风杀虫。治阑尾炎,月经不调,崩漏,小儿疳积,蛔虫、蛲虫症。
中医认为痔疮多由平素湿热内积,过食辛辣燥烈食物,或恣意饮酒,或因久坐而血脉不行,或经常大便秘结,或久痢等原因,以致浊气瘀血注肛门所致,郁热蕴结大肠,灼伤血络迫血下行。痔疮的基本病机为气机郁滞,郁而发热,火郁之成,其因有四:一为外邪阻遏,气不畅达; 二为情志所伤,气机郁结;三为正气虚馁,无力出入升降;四为饮食劳倦,损伤脾胃,升降悖逆,阳郁不达。气虚或气滞是主要的病理基础,郁热、血瘀是重要的致病因素,三者互为因果,即热可致郁、致瘀;郁可致瘀,郁为瘀的前身;瘀郁也可致热邪不散,热愈炽盛。其病机变化常相互影响,致使疾病病程迁延难愈。本病和肺、脾、胃相关;从病 机讲,心主血,“诸痛痒疮皆属于心”,肝主疏泄,肝气郁结,不得发散,化火成毒,故心、 肝两脏亦关系密切。中医讲 “气有余便是火”,“六气皆能从火化”,五志郁久亦可化火,火郁,是内热 (尤其是湿热) 产生的主要原因之一,而痔疮就是这种“火郁”证外在表现之一, 治疗的方法,当遵照《 内经》“火郁则发之”之理。
组方分析:方中,僵蚕辛平气轻且浮而升阳,具驱风解痉、清热解郁、升清化浊、化痰散结之功;大黄味苦性寒,气味俱厚,沉而降,具攻积滞、清湿热、解毒消痈、导瘀血之功。因清阳升则浊阴降,浊阴降才能清阳升,升清降浊互为因果,故僵蚕升清与大黄泄浊共为君药,以复升降之职。
姜黄辛苦而温有辛散、苦泄、温通之能,《备要》:理血中之气,下气破血,除风消肿,功力烈于郁金。《寒温条辩》:降阴中之浊阴……祛邪伐恶,行气散郁。下气最捷,破血利通。枳壳苦酸、性微寒,《日华子本草》:健脾开胃,调五脏,下气,止呕逆,消痰。具有理气宽中,行滞消胀之功。因姜黄和枳壳降泄浊阴,祛邪伐恶,行气活血,使内外通合而帮助大黄之泄浊,使痰瘀消散,以为臣。蝉蜕性寒气轻擅于疏风散热,透疹止痒,祛风解痉;《寒温条辩》:得土木余气所化,升也,阳中之阳也。荆芥味辛微苦、性微温,具有解表散风,透疹,消疮肿之功,《本经》:主寒热,鼠瘘,瘰疬生疮,破结聚气,下瘀血,除湿痹。蝉蜕和荆芥祛风胜湿,透疹疮肿,以其升清胜湿,辅僵蚕之升清化浊而为臣。
炒槐米凉血止血,清肝泻火,《日华子本草》:治五痔,心痛,眼赤,杀腹藏虫及热,治皮肤风,并肠风泻血,赤白痢。侧柏叶性微寒,味苦涩。凉血止血,祛风湿,散肿毒。《本草正》:善清血凉血,去湿热湿痹,骨节疼痛。炒槐米和侧柏叶泄肺逆,泻肝火,凉血止血、清血分之热,为佐药。
珠儿参偏于走下焦的肠道,把肠道积浊往下排,具有益气破滞消瘤,去邪养正,养阴清肺,散瘀止血,定痛之功。大血藤专走下焦,清热解毒,活血,祛风止痛。善治肠道息肉,肠痈腹痛,热毒疮疡,和珠儿参共为使药,引药入肛门。
诸药合用集宣、清、下、和于一方,寒温并用,升降相因,宣通三焦,条达气血,使周身气血流畅;既升清阳也降浊邪,既宣肺气也散郁火,去邪热通腑气,解邪毒活血络,宣泄郁热,调畅气机,使邪热有外透下行之路,病理产物(湿浊、痰、瘀)有外达内消之机,共奏升清降浊祛湿、凉血化瘀止血,疏风消肿止痛之功。本发明药物经过多年研究,临床治疗效果明显,治愈率为46%以上,总有效率为96%以上,具有疗效好、治愈率高、无副作用等特点。本发明的肠溶制剂,可克服胃强酸、光、热等内外环境对有效成分的破坏,增加药物的稳定性,确保活性成分在肠道力完全释放,充分发挥药物的疗效。本发明制备的肠溶制剂在人工胃液中耐酸力良好,人工肠液中溶出迅速且完全,工艺稳定;制剂成品质量均一稳定,临床应用安全可靠,无突释风险,极大的降低了药物副作用。
具体实施方式
下面结合实施例对本发明进一步说明。
实施例1:普通颗粒剂的制备
处方:炒槐米420g、侧柏叶480g、枳壳240g、荆芥240g、僵蚕300g、蝉蜕240g、姜黄360g、大黄240g、珠儿参240g、大血藤480g。
制备工艺:取槐米、侧柏叶、珠儿参、大血藤和姜黄,加12倍量50%的乙醇提取2次,每次1.0小时,合并醇提取液减压回收乙醇;荆芥加水12倍量,浸泡3小时后,回流提取8小时提取挥发油,得挥发油2.5ml,挥发油采用β-环糊精包合制得β-环糊精包合粉,即挥发油与β-环糊精比例为1:10,加入3倍量的30%的乙醇,胶体磨碾磨时间为60min,分离,干燥得β-环糊精包合粉,备用。上述两药渣与其余枳壳、僵蚕、蝉蜕和大黄药材混合,加8倍量水提取2次,每次1.5小时;合并上述提取液浓缩至相对密度1.25(60 ℃),减压干燥,粉碎,得干粉655g;干粉加入微晶纤维素80g和甘露醇245和β-环糊精包合粉充分混匀,干式制粒,整粒,包装(10g/袋),即得颗粒剂1000g。
实施例2:普通颗粒剂的制备
处方:炒槐米500g、侧柏叶500g、枳壳250g、荆芥250g、僵蚕250g、蝉蜕250g、姜黄500g、大黄250g、珠儿参250g、大血藤750g。
制备工艺:取槐米、侧柏叶、珠儿参、大血藤和姜黄,加8倍量70%的乙醇提取2次,每次1.0小时,合并醇提取液减压回收乙醇;荆芥加水15倍量,浸泡3小时后,回流提取8小时提取挥发油,得挥发油2.5ml,挥发油采用β-环糊精包合制得β-环糊精包合粉,即挥发油与β-环糊精比例为1:10,加入3倍量的30%的乙醇,胶体磨碾磨时间为60min,分离,干燥得β-环糊精包合粉,备用。上述两药渣与其余枳壳、僵蚕、蝉蜕和大黄药材混合,加12倍量水提取2次,每次1.0小时;合并上述提取液浓缩至相对密度1.25(60 ℃),减压干燥,粉碎,得干粉825g;干粉加入微晶纤维素40g和甘露醇120和β-环糊精包合粉充分混匀,干式制粒,整粒,包装(10g/袋),即得颗粒剂1000g。
实施例3:肠溶胶囊的制备
处方:炒槐米1000g、侧柏叶1000g、枳壳500g、荆芥500g、僵蚕500g、蝉蜕500g、姜黄750g、大黄500g、珠儿参500g、大血藤1250g。
制备工艺:取槐米、侧柏叶、珠儿参、大血藤和姜黄,加12倍量70%的乙醇提取2次,每次1.0小时,合并醇提取液减压回收乙醇;荆芥加水12倍量,浸泡3小时后,回流提取8小时提取挥发油得1.5ml,挥发油采用β-环糊精包合制得β-环糊精包合粉,即挥发油与β-环糊精比例为1:6,加入3倍量的30%的乙醇,胶体磨碾磨时间为60min,分离,干燥得β-环糊精包合粉,备用;上述两药渣与其余枳壳、僵蚕、蝉蜕和大黄药材混合,加10倍量水提取2次,每次1.5小时;合并上述提取液浓缩至相对密度1.05,上大孔吸附树脂进行吸附,水洗去杂质,70%的乙醇洗脱,收集洗脱液,浓缩干燥,粉碎,制得精制干粉415g;加入85g微晶纤维素,混合、干法制粒、整粒得半成品颗粒,取肠溶衣材料尤特奇L30D-55,加乙醇搅拌均匀,制成20%浓度的肠溶包衣液混悬液,用流化床对中间体颗粒进行包衣,包衣增重20%,包衣结束后,40℃流化干燥30min,即得肠溶颗粒,装胶囊(0.5g/粒),即得肠溶胶囊1300粒。
实施例4:肠溶胶囊的制备
处方:炒槐米750g、侧柏叶750g、枳壳450g、荆芥450g、僵蚕600g、蝉蜕450g、姜黄600g、大黄450g、珠儿参450g、大血藤900g。
制备工艺:取槐米、侧柏叶、珠儿参、大血藤和姜黄,加8倍量50%的乙醇提取2次,每次1.0小时,合并醇提取液减压回收乙醇;荆芥加水12倍量,浸泡3小时后,回流提取8小时提取挥发油得4.5ml,挥发油采用β-环糊精包合制得β-环糊精包合粉,即挥发油与β-环糊精比例为1:8,加入3倍量的30%的乙醇,胶体磨碾磨时间为60min,分离,干燥得β-环糊精包合粉,备用;上述两药渣与其余枳壳、僵蚕、蝉蜕和大黄药材混合,加8倍量水提取2次,每次1.5小时;合并上述提取液浓缩至相对密度1.02,上大孔吸附树脂进行吸附,水洗去杂质,50%的乙醇洗脱,收集洗脱液,浓缩干燥,粉碎,制得精制干粉350g;加入70g乳糖,混合、干法制粒、整粒得半成品颗粒,取肠溶衣材料尤特奇尤特奇L100,加乙醇搅拌均匀,制成20%浓度的肠溶包衣液混悬液,用流化床对中间体颗粒进行包衣,包衣增重20%,包衣结束后,40℃流化干燥30min,即得肠溶颗粒,装胶囊(0.5g/粒),即得肠溶胶囊1000粒。
实施例5:临床研究实验
一、临床资料
1、一般资料:
收集2011年2月-2014年2月聊城市人民医院的门诊患者321,其中治疗组1为124人,治疗组2为116人,①内痔组病例71例,男性30例,女性41例,年龄20-65岁,平均年龄45.5岁,病程6个月-3年。以排便时流血,大便困难,有坠胀感,有肿物脱出肛门,伴有肛门潮湿或有粘液为主诉。②外痔组病例共82例,男性35例,女性47例,年龄18 -68岁,平均年龄44.7岁,病程6个月-3年。以肛门有肿块,疼痛激烈,坠胀为主诉。③混合痔组共87例,男性37例,女性50例,年龄16-70岁,平均年龄44.5岁,病程6个月-3年。兼有内外痔双重特征,以肛门有肿块、坠胀、疼痛、反复发作为主诉。对照组81人,其中内痔23人,外痔25人,混合痔33人。
2、诊断标准
参照1994年国家中医药管理局制定的《中华人民共和国中医药行业标准·中医肛肠科病证诊断疗效标准》进行诊断并纳入观察对象。
二、治疗方法
(1)治疗组1:采用实施例2制备的颗粒剂,口服治疗,颗粒剂每次一袋,每日3次。
(2)治疗组2:采用实施例3制备的肠溶胶囊,口服治疗,每次6粒,每日3次。
(3)对照组:口服痔炎消颗粒(广西济民制药厂),每次10-20g,一日3次。
7天为1疗程,观察2个疗程统计疗效。患者治疗期间均停用其他口服及外用药且同时注意饮食清淡。
三、疗效评定标准
内痔疗效评定标准:
痊愈:肿、痛、痒消失,便后无出血,肛肠镜检查痔粘膜恢复正常,痔核消失;显效:排便时流血消失,肛门潮湿或有粘液症状消失,肛门肿物脱出现象极少发生;有效:偶尔出现排便时流血,肛门潮湿或有粘液症状消失,肛门肿物脱出略微减少;无效:主诉症状无改变。
外痔疗效评定标准:
痊愈:肿、痛、痒消失,便后无出血,肛肠镜检查痔粘膜恢复正常,痔核消失;显效:疼痛、坠胀及肛门肿块基本消失;有效:疼痛、坠胀感明显减轻,指诊检查肛门肿块明显减小:无效:主诉症状无改变。
混合痔疗效评定标准:
痊愈:肿、痛、痒消失,便后无出血,肛肠镜检查痔粘膜恢复正常,痔核消失;显效:疼痛、坠胀及肛门肿块基本消失,排便时流血消失,肛门潮湿或有粘液症状消失;有效:疼痛、坠胀感明显减轻,指诊检查肛门肿块明显减小,肛门肿物脱出减少;无效:主诉症状无改变。
四、治疗结果
治疗组1共124例,其中痊愈58例,占46.8%;显效37例,占29.8%;有效25例,占20.2%;无效4例,占3.2%,总有效率为96.77%。治疗组2共116例,其中痊愈56例,占48.3%;显效35例,占30.2%;有效21例,占18.1%;无效4例,占3.4%,总有效率为96.55%。对照组共81例,其中治愈21例,占26.3%;显效35例,占43.8%;有效11例,占13.8%;无效14例,占17.5%;总有效率为82.72%。结果显示,两治疗组的临床效果接近或相同,其痊愈率和有效率明显好于对照组。
Claims (8)
1.一种治疗痔疮的药物组合物,其特征在于由以下重量份的药物组成:炒槐米10~35份、侧柏叶10~40份、枳壳5~20份、荆芥5~20份、僵蚕5~25份、蝉蜕5~20份、姜黄10~30份、大黄5~20份、珠儿参5-20份、大血藤15-40份。
2.根据权利要求1所述的一种治疗痔疮的药物组合物,其特征在于由以下重量份的药物组成:炒槐米20~25份、侧柏叶20~25份、枳壳10~15份、荆芥10~15份、僵蚕10~20份、蝉蜕10~15份、姜黄15~20份、大黄10~15份、珠儿参10-15份、大血藤25-30份。
3.根据权利要求1或2所述的治疗痔疮的药物组合物,其特征在于:所述药物组合物的剂型为颗粒剂、肠溶片或肠溶胶囊。
4.一种权利要求3所述的治疗痔疮的颗粒剂的制备方法,其特征在于包括以下步骤:取炒槐米、侧柏叶、珠儿参、大血藤和姜黄,加8-12倍量50-70%的乙醇提取2次,每次0.5-1.0小时,合并醇提取液减压回收乙醇;荆芥加水12-15倍量,浸泡3小时后,回流提取8小时提取挥发油,挥发油采用β-环糊精包合制得β-环糊精包合粉;上述两药渣与其余枳壳、僵蚕、蝉蜕和大黄药材混合,加8-10倍量水提取2次,每次1.0-1.5小时;合并上述提取液浓缩至相对密度1.25(60 ℃),减压干燥,粉碎,得干粉;干粉加入适量辅料和β-环糊精包合粉充分混匀,干式制粒,整粒,包装,即得颗粒剂。
5.根据权利要求4所述的治疗痔疮的颗粒剂的制备方法,其特征在于:所述辅料为重量比为1:3的微晶纤维素和甘露醇,所述辅料的重量为干粉重量的20-50%。
6.一种权利要求3所述的治疗痔疮的肠溶胶囊的制备方法,其特征在于包括以下步骤:取炒槐米、侧柏叶、珠儿参、大血藤和姜黄,加8-12倍量50-70%的乙醇提取2次,每次0.5-1.0小时,合并醇提取液减压回收乙醇;荆芥加水12-15倍量,浸泡3小时后,回流提取8小时提取挥发油,挥发油采用β-环糊精包合制得β-环糊精粉;上述两药渣与其余枳壳、僵蚕、蝉蜕和大黄药材混合,加8-10倍量水提取2次,每次1.0-1.5小时;合并上述提取液浓缩至相对密度1.02-1.06,上大孔吸附树脂进行吸附,水洗去杂质,50-70%的乙醇洗脱,收集洗脱液,浓缩干燥,粉碎,制得精制干粉;加入适量填充剂,混合、干法制粒、整粒得半成品颗粒,取肠溶衣材料混悬液用流化床对中间体颗粒进行包衣,包衣增重10%-30%,包衣结束后,40℃流化干燥30min,即得肠溶颗粒,装胶囊,即得肠溶胶囊。
7.根据权利要求6所述的治疗痔疮的肠溶胶囊的制备方法,其特征在于:所述填充剂为乳糖、微晶纤维素、微粉硅胶、硫酸钙、淀粉中的一种或几种,所述填充剂的重量为精制干粉重量的20-30%。
8.根据权利要求6所述的治疗痔疮的肠溶胶囊的制备方法,其特征在于:所述肠溶衣材料为尤特奇L100或尤特奇S100或尤特奇L30D-55; 包衣增重优选增重为20%。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410429302.0A CN104147536B (zh) | 2014-08-28 | 2014-08-28 | 一种治疗痔疮的药物组合物及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410429302.0A CN104147536B (zh) | 2014-08-28 | 2014-08-28 | 一种治疗痔疮的药物组合物及其制备方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN104147536A true CN104147536A (zh) | 2014-11-19 |
| CN104147536B CN104147536B (zh) | 2016-08-31 |
Family
ID=51873299
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410429302.0A Expired - Fee Related CN104147536B (zh) | 2014-08-28 | 2014-08-28 | 一种治疗痔疮的药物组合物及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104147536B (zh) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105521329A (zh) * | 2015-12-24 | 2016-04-27 | 邵明红 | 一种痔疮术后清洗护理液 |
| CN105688055A (zh) * | 2016-03-14 | 2016-06-22 | 况成英 | 一种治疗尿毒症的药物及其制备方法 |
| CN107595984A (zh) * | 2017-09-27 | 2018-01-19 | 江苏省中医院 | 一种治疗痔疮出血的中药熏洗复方制剂及制备方法 |
| CN109331148A (zh) * | 2018-11-29 | 2019-02-15 | 深圳农畉食品开发集团有限公司 | 一种治疗猪卡它性肠胃炎的药物组合物及其制备方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101601765B (zh) * | 2009-07-29 | 2011-01-12 | 冯玉林 | 肛肠康洗液及其制备方法 |
| CN103566287A (zh) * | 2012-08-07 | 2014-02-12 | 天津滨海人和酒业有限公司 | 治疗荨麻疹的中药 |
-
2014
- 2014-08-28 CN CN201410429302.0A patent/CN104147536B/zh not_active Expired - Fee Related
Non-Patent Citations (1)
| Title |
|---|
| 张瑾: "赤小豆当归散合槐花散治痔疾", 《江西中医药》 * |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105521329A (zh) * | 2015-12-24 | 2016-04-27 | 邵明红 | 一种痔疮术后清洗护理液 |
| CN105688055A (zh) * | 2016-03-14 | 2016-06-22 | 况成英 | 一种治疗尿毒症的药物及其制备方法 |
| CN107595984A (zh) * | 2017-09-27 | 2018-01-19 | 江苏省中医院 | 一种治疗痔疮出血的中药熏洗复方制剂及制备方法 |
| CN109331148A (zh) * | 2018-11-29 | 2019-02-15 | 深圳农畉食品开发集团有限公司 | 一种治疗猪卡它性肠胃炎的药物组合物及其制备方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN104147536B (zh) | 2016-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101612360B (zh) | 治疗肝炎、肝硬化、肝癌的药物 | |
| CN103520572B (zh) | 一种用于治疗特应性皮炎的中药组合物及其制备方法 | |
| CN105749179A (zh) | 治疗代谢综合征的中药组合物 | |
| CN104147536A (zh) | 一种治疗痔疮的药物组合物及其制备方法 | |
| CN103520655A (zh) | 一种治疗寻常型银屑病的中药组合物及其制备方法 | |
| CN102362974A (zh) | 一种治疗荨麻疹的中药组合物 | |
| CN104042971A (zh) | 用于治疗阴虚毒热型肺癌的药物组合物及其制备方法 | |
| CN104998197A (zh) | 一种用于治疗肝癌的中药组合物 | |
| CN104888081A (zh) | 一种治疗肾阳亏虚型经行泄泻的冲剂及其制备方法 | |
| CN103860773A (zh) | 用于治疗心肌缺血的中药组合物及其制备方法 | |
| CN102935190B (zh) | 一种用于阑尾炎术前术后护理的药丸及制备方法 | |
| CN104758754A (zh) | 一种治疗肾气虚衰型前列腺增生的药物及制备方法 | |
| CN100431578C (zh) | 一种治疗前列腺增生的中药制剂 | |
| CN105412665A (zh) | 一种治疗麻疹的药物及其制备方法 | |
| CN104984184A (zh) | 一种治疗小儿阑尾脓肿的药物组合物及其制备方法 | |
| CN104352851A (zh) | 一种预防及治疗胰腺炎的中药蜜丸及其制备方法 | |
| CN104825892B (zh) | 一种治疗排卵期出血的中药制剂及其制备方法 | |
| CN112870317A (zh) | 一种治疗肥胖的中药及其制备方法 | |
| CN103028028B (zh) | 一种治疗原发性肝癌的中药 | |
| CN106166251A (zh) | 一种用于治疗哮喘的中药制剂及其制备方法 | |
| CN104940777A (zh) | 一种治疗肝旺脾弱型经行泄泻的冲剂及其制备方法 | |
| CN105267815A (zh) | 一种治疗小儿肺肾两虚型哮喘的喷雾剂及其制备方法 | |
| CN104042924A (zh) | 一种治疗气血亏虚型骨性关节炎的中药制剂及其制备方法 | |
| CN105687362A (zh) | 慢性痢疾活血止痢丸 | |
| CN105267895A (zh) | 用于治疗牛产后血瘀型胞衣不下的药物及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160831 Termination date: 20180828 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |